RAYMOND W COHEN Insider Trading $SPPI SPECTRUM PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RAYMOND W COHEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RAYMOND W COHEN. RAYMOND W COHEN is Director in BIOLIFE SOLUTIONS INC ($BLFS) and CEO in CARDIAC SCIENCE INC ($DFIB) and Chairman and CEO in CARDIAC SCIENCE INC ($DFIB) and Director in SPECTRUM PHARMACEUTICALS INC ($SPPI) and Chief Executive Officer in Axonics Modulation Technologies, Inc. ($AXNX).
RAYMOND W COHEN in SPECTRUM PHARMACEUTICALS INC
Trading Symbol: SPPIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RAYMOND W COHEN: Director
Holdings: 53,850 shares
Current Value: $267,096
Latest Transaction: Jun 21 2019
$SPPI Market Capitalization: $395.33M
$SPPI Previous Close: $4.96
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RAYMOND W COHEN in SPECTRUM PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AXNX, BLFS, DFIB, SPPI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2019 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 8.44 | 20,000 | 168,800 | 20,000 | |
Jun 21 2019 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 53,850 | 43.9 K to 53.9 K (+22.81 %) |
Jun 21 2019 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 8.44 | 20,000 | 168,800 | 20,000 | |
Jun 21 2019 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 53,850 | 43.9 K to 53.9 K (+22.81 %) |
Mar 18 2019 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 9.59 | 5,000 | 47,950 | 43,850 | 38.9 K to 43.9 K (+12.87 %) |
Jun 19 2018 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 19.95 | 20,000 | 399,000 | 20,000 | |
Jun 19 2018 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 38,850 | 28.9 K to 38.9 K (+34.66 %) |
May 15 2018 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Sell | S | 18.32 | 9,275 | 169,918 | 28,850 | 38.1 K to 28.9 K (-24.33 %) |
Jun 29 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 7.54 | 625 | 4,713 | 43,125 | 43.8 K to 43.1 K (-1.43 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 6.48 | 20,000 | 129,600 | 20,000 | |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 6.48 | 20,000 | 129,600 | 20,000 | |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 43,750 | 33.8 K to 43.8 K (+29.63 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 43,750 | 33.8 K to 43.8 K (+29.63 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 6.48 | 2,500 | 16,200 | 33,750 | 36.3 K to 33.8 K (-6.90 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 6.48 | 2,500 | 16,200 | 33,750 | 36.3 K to 33.8 K (-6.90 %) |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 6.33 | 20,000 | 126,600 | 20,000 | |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 36,250 | 26.3 K to 36.3 K (+38.10 %) |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 6.33 | 2,500 | 15,825 | 26,250 | 28.8 K to 26.3 K (-8.70 %) |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 6.47 | 625 | 4,044 | 28,750 | 29.4 K to 28.8 K (-2.13 %) |
Jul 08 2015 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 6.96 | 625 | 4,350 | 29,375 | 30 K to 29.4 K (-2.08 %) |
Jul 01 2015 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 6.96 | 20,000 | 139,200 | 20,000 | |
Jul 01 2015 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 30,000 | 20 K to 30 K (+50.00 %) |
Page: 1